Tufts Report: Orphan Drugs Take an Average of 15 Years to Launch

Drug Industry Daily
Orphan drug development takes 18 percent longer to reach the product launch stage than new drugs across the board, according to a new analysis from the Tufts Center for the Study of Drug Development.

To View This Article:


Subscribe To Drug Industry Daily